Dr Nyasha Mafirakureva
Bachelors, MSc, PhD
Current positions
Honorary Research Fellow
Bristol Medical School (THS)
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Research interests
I am a Health Economist interested in evaluating global health care programmes. I am currently workin on economic evaluations of targeted prevention and treatment models of hepatitis C virus in in low and middle income countries. This work largely involves measuring costs and outcomes; and assessing cost-effectiveness of healthcare interventions in infectious diseases.
Projects and supervisions
Research projects
Building the evidence base for cost-effective treatment scale-up for hepatitis C virus in Pakistan healthcare settings
Principal Investigator
Role
Collaborator
Description
Pakistan’s expanding hepatitis C virus (HCV) epidemic makes up >10% of the global disease burden. Increasing accessibility to highly-effective curative HCV treatment presents an opportunity for healthcare providers in Pakistan…Managing organisational unit
Bristol Medical School (PHS)Dates
15/11/2018 to 31/07/2019
Building a Sub-Saharan African MuSculOskeletal Network; SAMSON
Principal Investigator
Role
Co-Investigator
Description
The burden of musculoskeletal disease is growing across Africa, with implications throughout the lifecourse. Currently research and healthcare capacity to address musculoskeletal disease is limited across the region. Ultimately SAMSON…Managing organisational unit
Bristol Medical School (THS)Dates
09/02/2018 to 31/07/2018
Publications
Recent publications
27/01/2023The healthcare system costs of hip fracture care in South Africa
Osteoporosis International
Integrating Hepatitis C Care for opioid substitution treatment patients attending general practice
Interactive Journal of Medical Research
Modelling the Impact of HIV and HCV Prevention and Treatment Interventions Among People Who Inject Drugs in Kenya
AIDS
An intensive model of care for hepatitis C virus screening and treatment with direct-acting antivirals in people who inject drugs in Nairobi, Kenya
Addiction
Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar
BMJ Global Health